{"news_desk": "Business", "print_page": null, "section_name": "Business Day", "subsection_name": "Dealbook", "document_type": "blogpost", "multimedia": [{"height": 126, "subtype": "wide", "legacy": {"widewidth": "190", "wide": "images/2015/01/12/business/12skymain1/12skymain1-thumbWide.jpg", "wideheight": "126"}, "type": "image", "width": 190, "url": "images/2015/01/12/business/12skymain1/12skymain1-thumbWide.jpg"}, {"height": 394, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "394", "xlarge": "images/2015/01/12/business/12skymain1/12skymain1-articleLarge.jpg"}, "type": "image", "width": 600, "url": "images/2015/01/12/business/12skymain1/12skymain1-articleLarge.jpg"}, {"height": 75, "subtype": "thumbnail", "legacy": {"thumbnail": "images/2015/01/12/business/12skymain1/12skymain1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "type": "image", "width": 75, "url": "images/2015/01/12/business/12skymain1/12skymain1-thumbStandard.jpg"}], "abstract": "The Irish drug maker Shire is paying a premium for NPS Pharmaceuticals, which is based in New Jersey, as part of its effort to recover from its botched sale to AbbVie last year.", "type_of_material": "Blog", "word_count": "802", "lead_paragraph": null, "pub_date": "2015-01-11T13:27:48Z", "_id": "54b2c0fc38f0d82eb90f0b68", "byline": {"original": "By DAVID GELLES", "person": [{"rank": 1, "role": "reported", "firstname": "David", "organization": "", "lastname": "GELLES"}]}, "source": "The New York Times", "snippet": "The Irish drug maker Shire is paying a premium for NPS Pharmaceuticals, which is based in New Jersey, as part of its effort to recover from its botched sale to AbbVie last year.", "web_url": "http://dealbook.nytimes.com/2015/01/11/shire-to-buy-nps-pharmaceuticals-for-5-2-billion/", "slideshow_credits": null, "blog": [], "keywords": [{"rank": "1", "is_major": "N", "value": "AbbVie Inc", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "NPS Pharmaceuticals Inc", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Shire PLC", "name": "organizations"}, {"rank": "1", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}], "headline": {"main": "Shire to Buy NPS Pharmaceuticals for $5.2 Billion", "print_headline": "Shire to Buy NPS Pharmaceuticals for $5.2 Billion", "kicker": "DealBook"}}